Mara B. Antonoff

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

Tina Cascone, William N. William, Annikka Weissferdt et al. · Nature Medicine · 2021 · 604 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery

Joe Y. Chang, Reza J. Mehran, Lei Feng et al. · The Lancet Oncology · 2021 · 312 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Does Tweeting Improve Citations? One-Year Results From the TSSMN Prospective Randomized Trial

Jessica G.Y. Luc, Michael A. Archer, Rakesh C. Arora et al. · The Annals of Thoracic Surgery · 2020 · 219 citations

Management, Translational Sciences, Science Communication +6

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

Tina Cascone, Cheuk Hong Leung, Annikka Weissferdt et al. · Nature Medicine · 2023 · 206 citations · Full text

Medicine, Oncology, Pharmacology +17

Enhanced Recovery Decreases Pulmonary and Cardiac Complications After Thoracotomy for Lung Cancer

Robert M. Van Haren, Reza J. Mehran, Gabriel E. Mena et al. · The Annals of Thoracic Surgery · 2018 · 199 citations · Full text

Medicine, Perioperative Medicine, Surgery +16